George Adel: Advancing Stroke Management at El Mabara Hospital Through Collaborative ICU Engagement
George Adel, Product Specialist at EVER Pharma (Africa), shared on LinkedIn:
”When you position yourself as a scientific resource rather than just a representative, you don’t just participate in the market you help shape it.
Today at El Mabara Hospital, it was all about partnering with the ICU team to elevate stroke management.
By aligning the clinical benefits of Cerebrolysin (right regimen) with the latest global guidelines, we aren’t just discussing a product, we are actively driving market growth and helping doctors optimize patient recovery.
A sincere thank you to Dr. Peter Wadie for always challenging me to grow and giving me the professional backing to execute these steps.
And to Dr. Sally Moheb, thank you for your encouragement and for always believing in my vision it really drives me to keep growing.”
Stay updated with Hemostasis Today.
-
Aug 21, 2026, 12:42Moustafa Abdou: Diagnosis and Management of Pyruvate Kinase Deficiency
-
Aug 21, 2026, 12:38Luluva Ghadiyali: Modern Approaches to Aplastic Anemia
-
Aug 21, 2026, 12:34Kellie Machlus: Animal Models Driving Progress in Thrombosis Research
-
Aug 21, 2026, 12:08Amy Allen Whitfield: Helping to Proceed Bleeding Disorders Care
-
Aug 21, 2026, 11:53Jan Terje Andersen: Harnessing Placental Biology for Therapeutic Engineering
-
Aug 21, 2026, 11:02Severe ITP, Critical Bleeding, and the Challenge of Platelet Testing – RPTH Journal
-
Aug 21, 2026, 10:46Arwa Z. Al-Riyami: Looking Ahead to ISBT Muscat 2029
-
Aug 21, 2026, 10:42Janine Mothershed: What Is Romiplostim and How Does It Work in Immune Thrombocytopenia?
-
Aug 21, 2026, 10:33Omar Alkharabsheh: Excited to Build the Future of Hematologic Malignancy Care in Central Florida